版本:
中国

BRIEF-Tetra Bio-Pharma, Intelgenx sign agreement for development, commercialization of Dronabinol XL tablet

April 3 Tetra Bio-pharma Inc:

* Tetra Bio-pharma and Intelgenx announce the signing of a definitive agreement for the development and commercialization of a Dronabinol XL tablet

* Tetra Bio-pharma Inc - definitive agreement follows binding term sheet between two companies that was announced on February 9, 2017

* Tetra Bio-Pharma Inc - pursuant to definitive agreement, Tetra has exclusive rights to sell product in North America

* Tetra Bio-Pharma Inc - Tetra will have a right of first negotiation for territories outside of United States and Canada Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐